SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -99.3% | 1,065 | -99.0% | 0.00% | – |
| Q1 2022 | $142,000 | +1.4% | 109,943 | +0.1% | 0.00% | – |
| Q4 2021 | $140,000 | -41.7% | 109,856 | -0.2% | 0.00% | – |
| Q3 2021 | $240,000 | -41.6% | 110,062 | +0.3% | 0.00% | – |
| Q2 2021 | $411,000 | +16.1% | 109,686 | +1.1% | 0.00% | – |
| Q1 2021 | $354,000 | -4.3% | 108,500 | 0.0% | 0.00% | – |
| Q4 2020 | $370,000 | -14.0% | 108,500 | +2.9% | 0.00% | -100.0% |
| Q3 2020 | $430,000 | +20.8% | 105,400 | 0.0% | 0.00% | – |
| Q2 2020 | $356,000 | +109.4% | 105,400 | +44.2% | 0.00% | – |
| Q1 2020 | $170,000 | -53.6% | 73,100 | -27.3% | 0.00% | – |
| Q4 2019 | $366,000 | -61.3% | 100,600 | -11.8% | 0.00% | -100.0% |
| Q3 2019 | $946,000 | -3.7% | 114,100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $982,000 | -9.4% | 114,100 | +12.5% | 0.00% | 0.0% |
| Q1 2019 | $1,084,000 | +22.2% | 101,400 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $887,000 | -52.1% | 101,400 | -8.0% | 0.00% | -50.0% |
| Q3 2018 | $1,851,000 | -19.9% | 110,200 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $2,310,000 | +50.3% | 110,200 | +15.4% | 0.00% | +50.0% |
| Q1 2018 | $1,537,000 | -12.6% | 95,500 | +2.9% | 0.00% | 0.0% |
| Q4 2017 | $1,759,000 | +55.3% | 92,800 | +15.3% | 0.00% | +100.0% |
| Q3 2017 | $1,133,000 | +88.8% | 80,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $600,000 | +37.0% | 80,500 | +19.4% | 0.00% | 0.0% |
| Q1 2017 | $438,000 | +61.0% | 67,401 | +10.0% | 0.00% | – |
| Q4 2016 | $272,000 | -4.9% | 61,300 | 0.0% | 0.00% | – |
| Q3 2016 | $286,000 | -29.0% | 61,300 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $403,000 | +3.3% | 61,300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $390,000 | +5.4% | 61,300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $370,000 | +0.8% | 61,300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $367,000 | -55.1% | 61,300 | -48.7% | 0.00% | 0.0% |
| Q2 2015 | $817,000 | +24.5% | 119,410 | +10.6% | 0.00% | 0.0% |
| Q1 2015 | $656,000 | -12.3% | 108,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $748,000 | -14.9% | 108,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $879,000 | -6.9% | 108,000 | -7.0% | 0.00% | 0.0% |
| Q2 2014 | $944,000 | +0.2% | 116,100 | -3.3% | 0.00% | 0.0% |
| Q1 2014 | $942,000 | -11.4% | 120,100 | 0.0% | 0.00% | -50.0% |
| Q4 2013 | $1,063,000 | +5.5% | 120,100 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,008,000 | +12.5% | 120,100 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $896,000 | – | 120,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |